Search research articles
Contact Us
Filters
Showing results (351-360 of 367) with videos related to
Page
of 37
Sort By:
Journal of Infection in Developing Countries
|
November 5, 2024
Assessing COVID-19 outcomes among healthcare workers: a retrospective study
Nawfal R Hussein, Ronahi Y Ibrahim, Shameran S Daniel, et al.
Frontiers in Oncology
|
May 14, 2025
Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancer
Sara Corvigno, Jun Yao, Amma Asare, et al.
Molecular Cancer Therapeutics
|
September 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Public Health in Practice (Oxford, England)
|
January 8, 2026
Insights into cardiovascular health: Knowledge, attitudes, and practices in the Kurdistan region of Iraq
Ahmed A Mosa, Avan Saadi Saleh, Osama Abdullah M Taher, et al.
Biorxiv : the Preprint Server for Biology
|
December 22, 2025
PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer
Sahar F Bannoura, Husain Yar Khan, Amro Aboukameel, et al.
JCO Oncology Advances
|
May 7, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations
Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways
Md Hafiz Uddin, Zaid Mahdi, Irfana Muqbil, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma
Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, et al.
Seminars in Cancer Biology
|
May 5, 2015
Broad targeting of resistance to apoptosis in cancer
Ramzi M Mohammad, Irfana Muqbil, Leroy Lowe, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 367) with videos related to
Sort By:
Page
of 37
Journal of Infection in Developing Countries
|
November 5, 2024
Assessing COVID-19 outcomes among healthcare workers: a retrospective study
Nawfal R Hussein, Ronahi Y Ibrahim, Shameran S Daniel, et al.
Frontiers in Oncology
|
May 14, 2025
Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancer
Sara Corvigno, Jun Yao, Amma Asare, et al.
Molecular Cancer Therapeutics
|
September 13, 2023
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
Public Health in Practice (Oxford, England)
|
January 8, 2026
Insights into cardiovascular health: Knowledge, attitudes, and practices in the Kurdistan region of Iraq
Ahmed A Mosa, Avan Saadi Saleh, Osama Abdullah M Taher, et al.
Biorxiv : the Preprint Server for Biology
|
December 22, 2025
PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer
Sahar F Bannoura, Husain Yar Khan, Amro Aboukameel, et al.
JCO Oncology Advances
|
May 7, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations
Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways
Md Hafiz Uddin, Zaid Mahdi, Irfana Muqbil, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma
Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, et al.
Seminars in Cancer Biology
|
May 5, 2015
Broad targeting of resistance to apoptosis in cancer
Ramzi M Mohammad, Irfana Muqbil, Leroy Lowe, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Page
of 37